Request Sample of the Report on Global Serum Free and Specialty Media Market 2033 - Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies, and rise ...

Stock investors may look back at 2025 as the year of the takeover — one that delivered sizeable gains. “It’s going to be a ...

January 2025 Smartphone cameras have come a long way, but you probably still notice images that could ... We took stock of what features were available to free users and what was paywalled ...

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported fourth-quarter adjusted EPS of $12.07, up 2% year-over-year, beating the ...

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...

They are typically monoclonal antibodies selected to bind to a particular ... the authors show that anti-Mb RabMAb injection blocking the passage of free Mb through the glomerular filtration ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Leap Therapeutics (LPTX) lost 63% after announcing it will not run a Phase 3 trial for its lead asset sirexatamab in gastric cancer. Read more here.

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...